Australian Parliament Rape Trial Called Off Over Health Concerns
(Bloomberg) -- The retrial of an Australian political staffer accused of sexually assaulting a coworker at Parliament House was stopped after the head of public prosecutions said the plaintiff’s health would be at risk from any future hearings.
Most Read from Bloomberg
Musk’s Neuralink Hopes to Implant Computer in Human Brain in Six Months
Beverly Hills Cop Was California’s Highest-Paid Municipal Worker
An Arizona County’s Refusal to Certify Election Results Could Cost GOP a House Seat
Former Liberal National Coalition staffer Bruce Lehrmann was accused in 2021 of raping colleague Brittany Higgins on a couch in a minister’s office, an allegation that set off a storm of outrage across Australia and calls for greater protection of women in the workplace.
See: Women Fed Up With Flagrant Sexism Could Swing Australia Election
The first trial in Canberra earlier this year was called off early after allegations of juror misconduct. A second trial was due to be held in 2023, but on Friday the prosecutors announced they were dropping the charges over health concerns for Higgins.
Director of Public Prosecutions Shane Drumgold said Friday he received evidence from two medical experts that continuing with the trial would present “a significant and unacceptable risk to the life of the complainant.”
Read: Sexual Harassment Rife in Australian Parliament, Report Says
Drumgold said in the 20 years he’d worked as a public prosecutor he had never seen the “level of personal attack” that was leveled at Higgins, adding she handled it with “bravery, grace and dignity.”
“It is my hope that this will now stop and Miss Higgins will be allowed to heal,” he said.
Most Read from Bloomberg Businessweek
11 Hours With Sam Bankman-Fried: Inside the Bahamian Penthouse After FTX’s Fall
TikTok’s Viral Challenges Keep Luring Young Kids to Their Deaths
Forget Zoom Calls, Remote Work Startups Want to Build a Virtual Office
The Avatar Sequel Is a Make-or-Break Moment for Disney’s $71 Billion Fox Deal
©2022 Bloomberg L.P.